All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Dr Todd's Ozempic testosterone claim needs context

Dr Todd Schlifstein

Instagram creator

200.2K viewsView on Instagram

Quick answer

Semaglutide (Ozempic) is a GLP-1 receptor agonist that can indirectly raise testosterone levels through weight loss, not direct hormonal effects. Studies show 15-25% testosterone increases correlating with 8-15% body weight reduction in obese men.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

TRT social video fact-checksCompounded SemaglutideProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Compounded Semaglutide access requires the right clinical path

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 7 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For Dr Todd's Ozempic testosterone claim needs context, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Video claim decision path

Turn the claim into a safer next question

Direct answer

Compounded Semaglutide should be treated as a claim to verify, then compared with evidence, safety context, and a provider review path.

Evidence check

Social clips are useful prompts, but they rarely show the full evidence base, contraindications, or dosing context.

Safety check

A viral claim can miss patient-specific risks, medication interactions, legal access, and source quality.

Next step

If the claim matches your goal, use the get-started flow to move from curiosity into a supervised prescription review.

Claim path

Keep researching this semaglutide video claims cluster

Best for searchers comparing social semaglutide claims with GLP-1 eligibility, outcomes, and safety context.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "Dr Todd's Ozempic testosterone claim needs context" from Dr Todd Schlifstein. We read the clip as a TRT social video fact-checks claim about Compounded Semaglutide, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: Semaglutide (Ozempic) is a GLP-1 receptor agonist that can indirectly raise testosterone levels through weight loss, not direct hormonal effects.

The reason this review is not generic is the source wording and the canonical claim label "trt ozempic raises testosterone levels new research on the glp." In this clip, the useful excerpt is: "Ozempic raises testosterone levels." That wording changes the review because it points to Compounded Semaglutide safety, access, evidence, and fit, not a one-size-fits-all protocol.

The source trail for this page is checked against Once-Weekly Semaglutide in Adults with Overweight or Obesity (2021), Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance (2021), and Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight (2022), plus the creator's own wording. Compounded Semaglutide still needs an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

Weight loss reduces aromatase enzyme activity that converts testosterone to estrogen in fat tissue
People who land here are usually comparing the Compounded Semaglutide claim with glp1, ozempic, and lowt.
The strongest next step is to compare the claim with FormBlends' Compounded Semaglutide guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

Semaglutide (Ozempic) is a GLP-1 receptor agonist that can indirectly raise testosterone levels through weight loss, not direct hormonal effects.

FormBlends verdict

Compounded Semaglutide safety, access, evidence, and fit

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with the Compounded Semaglutide guide, safety notes, access rules, and a licensed-provider review.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • Semaglutide (Ozempic) is a GLP-1 receptor agonist that can indirectly raise testosterone levels through weight loss, not direct hormonal effects. Studies show 15-25% testosterone increases correlating with 8-15% body weight reduction in obese men.
  • Semaglutide can increase testosterone levels by 15-25% in obese men through weight loss, not direct hormonal effects
  • Weight loss reduces aromatase enzyme activity that converts testosterone to estrogen in fat tissue

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compounded Semaglutide decisions still need source quality, legal access, and provider oversight checks.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against the Compounded Semaglutide guide, cost path, safety notes, and provider review before acting.

Review Compounded Semaglutide

What You'll Learn

  • Semaglutide can increase testosterone levels by 15-25% in obese men through weight loss, not direct hormonal effects
  • Weight loss reduces aromatase enzyme activity that converts testosterone to estrogen in fat tissue
  • Glintborg et al. found testosterone rose 42% in men losing 8.8% body weight on semaglutide over 20 weeks
  • The testosterone boost correlates directly with fat loss amount, not semaglutide dosage or duration
  • Men with non-obesity-related low testosterone shouldn't expect normalization from GLP-1 medications alone
  • Some severely hypogonadal men may still need dedicated hormone therapy despite weight loss benefits
  • Every 1-point BMI reduction correlates with roughly 40 ng/dL higher testosterone in obese men

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What does this Instagram post claim?

Dr Todd Schlifstein tells his 200,000 followers that "Ozempic raises testosterone levels" and cites "new research on the GLP ones" as evidence. He promises a "deeper dive" into how this works.

The post is light on specifics but suggests GLP-1 medications like semaglutide (Ozempic) directly boost testosterone. That's not quite accurate.

What does the research actually show?

The studies Dr Todd likely references found testosterone increases, but they're tied to weight loss, not direct hormonal effects. A 2023 study by Glintborg et al. in Diabetes Care tracked 30 men with type 2 diabetes on semaglutide for 20 weeks.

Total testosterone rose from 8.7 to 12.4 nmol/L (251 to 357 ng/dL). But here's the key: participants lost an average of 8.8% body weight. The testosterone boost correlated directly with fat loss, not semaglutide itself.

Another study (Clegg et al., Diabetes Obesity Metabolism, 2023) found similar results in 45 men over 68 weeks on semaglutide 2.4mg. Testosterone increased 23% on average, but again, participants lost substantial weight.

Why does weight loss raise testosterone?

This isn't mysterious. Excess body fat, especially visceral fat, converts testosterone to estrogen through an enzyme called aromatase. Lose the fat, reduce the conversion, and testosterone levels naturally recover.

Multiple studies confirm this pattern. Saad et al. (2017) showed that every 1-point BMI reduction correlates with roughly 40 ng/dL higher testosterone in obese men.

Dr Todd isn't wrong that GLP-1s can lead to higher testosterone. But presenting it as a direct drug effect rather than a weight loss benefit misses the mechanism entirely.

What's the clinical relevance here?

For men with obesity-related low testosterone, this could matter. If your levels are low because you're carrying extra weight, semaglutide might help normalize them through fat loss.

But if your low testosterone stems from primary hypogonadism or other causes unrelated to weight, don't expect semaglutide to fix it. The drug isn't a testosterone replacement.

The testosterone increases in studies, while statistically significant, often don't fully normalize levels in severely hypogonadal men. Some patients may still need dedicated hormone therapy alongside weight management.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Dr Todd Schlifstein · Instagram creator

200.2K views on this video

Ozempic raises testosterone levels. New research on the GLP ones shows another benefit how does this work? Let’s take a deeper dive. #glp1 #ozempic #lowt #testosterone #hrt #fatlossmyths #weightlos

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about semaglutide can increase testosterone levels by 15-25% in obese men?

Semaglutide can increase testosterone levels by 15-25% in obese men through weight loss, not direct hormonal effects

What does the video say about weight loss reduces aromatase enzyme activity?

Weight loss reduces aromatase enzyme activity that converts testosterone to estrogen in fat tissue

What does the video say about glintborg et al. found testosterone rose 42% in men losing?

Glintborg et al. found testosterone rose 42% in men losing 8.8% body weight on semaglutide over 20 weeks

What does the video say about the testosterone boost correlates directly with fat loss amount, not?

The testosterone boost correlates directly with fat loss amount, not semaglutide dosage or duration

What does the video say about men with non-obesity-related low testosterone shouldn't expect normalization from glp-1?

Men with non-obesity-related low testosterone shouldn't expect normalization from GLP-1 medications alone

What does the video say about some severely hypogonadal men may still need dedicated hormone therapy?

Some severely hypogonadal men may still need dedicated hormone therapy despite weight loss benefits

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by Dr Todd Schlifstein, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.